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Background: Chronic dietary restriction (DR) has been shown to have beneficial effects on glucose homeostasis
and insulin sensitivity. These factors show rapid and robust improvements when rodents were crossed over from an
ad libitum (AL) diet to DR in mid life. We aimed to determine whether the beneficial effects induced by short-term
exposure to DR can be retained as a ‘metabolic memory’ when AL feeding is resumed (AL-DR-AL) and vice versa:
whether the effects of long-term DR can be reversed by a period of AL feeding (DR-AL-DR). C57BL/6 male and
female mice were used to examine sex differences (N = 10/sex/group). Mice were fed AL or DR from 3 until
15 months (baseline) and each dietary crossover lasted approximately 5 months.
Results: In females, body and fat mass were proportional to the changes in feeding regime and plasma insulin and
glucose tolerance were unaffected by the crossovers. However, in male mice, glucose tolerance and plasma insulin
levels were reversed within 6 to 12 weeks. When males returned to AL intake following 5 months DR (AL-DR-AL),
body mass was maintained below baseline, proportional to changes in fat mass. Glucose tolerance was also
significantly better compared to baseline.
Conclusions: Male mice retained a metabolic memory of 5 months of DR feeding in terms of reduced body mass
and improved glucose tolerance. This implies that some of the beneficial effects induced by a period of DR in adult
life may be beneficial, even when free feeding is resumed at least in males. However, under continuous DR, lifespan
extension was more prominent in females than in males.
Keywords: Dietary restriction, Glucose tolerance, Insulin sensitivity, Crossover, Metabolic memory, Sexual
dimorphism, Body mass, Hyperphagia, MouseBackground
In mammals, pancreatic β cells secrete insulin in propor-
tion to the concentration of circulating glucose. Insulin
then stimulates glucose uptake into skeletal muscle and adi-
pose tissue and decreases hepatic glucose production.
Defects in insulin secretion by the β cells can lead to hyper-
glycemia and the onset of type 2 diabetes [1]. Chronic diet-
ary restriction (DR) in C57BL/6 inbred mice has been
shown to have beneficial effects on glucose tolerance [2,3].
Additionally, improved insulin sensitivity and reductions in
plasma insulin during DR have been linked to the life
extending effects of DR in mice [4,5].* Correspondence: t.vonzglinicki@newcastle.ac.uk
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reproduction in any medium, provided the orAlthough chronic DR is known to lead to improve-
ments in glucose tolerance and insulin sensitivity, per-
haps more relevant for humans is whether only a short
period of DR has the same effects. Previous data show
this is indeed the case with only a short period of DR
(ad libitum (AL)-DR crossover), in people with type 2
diabetes [6] and in rodents [7-9].
However, very little is known about whether the beneficial
effects induced by short-term exposure to DR can have a
‘metabolic memory’ when AL feeding is resumed (AL-DR-
AL) and vice versa: whether the effects of long-term DR can
be reversed by a period of AL feeding (DR-AL-DR). We per-
formed these crossovers in laboratory mice to determine the
effects of such switches in feeding regimes on body compos-
ition as well as glucose and insulin sensitivity. The majority
of studies show that male rodents are more insulin resistantal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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whether there was sexual dimorphism in glucose tolerance
and insulin sensitivity in response to the dietary crossovers.
We show striking sexual dimorphism, whereby glucose tol-
erance and insulin sensitivity of female mice was relatively un-
perturbed by the crossovers. However, in males these
parameters improved within 6 to 12 weeks of the crossover
to DR and vice versa. Improved glucose tolerance and
reduced body mass were retained in males after returning to
AL feeding following 5 months DR, suggesting that several of
the potentially beneficial effects of short period of DR were
retained.
Results
Body mass and body composition
C57BL/6 mice were randomly assigned to a DR or an
AL group at 3 months of age (day 0 of the experiment).time (days)







































Figure 1 Body mass changes in double-crossover and long-term cont
Prior to the experiment starting (day −7), when mice were 3 months old th
groups (P >0.05). A 40% food restriction was initiated in the dietary restrict
mice/group in the crossover groups and from 280 (at start) to 48 (at the en
time under the indicated treatments in females (C) and males (D). Rates we
approximately linear range and are means ± SEM. Colors are as in (A) and (
**P <0.001 assessed using one-way analysis of variance (ANOVA)/Holm-SidThe majority of animals remained in their group until
they were killed for experiments at predetermined time
points or died naturally. In addition, ten mice per group
were assigned to a double-crossover experiment with the
first crossover at day 365 (15 months of age) and the
second (reverse) crossover at day 505 (about 20 months
of age). These mice were then killed at 25 months
of age.
We first compared body mass trajectories in the cross-
over groups to large single treatment control cohorts (AL-
only or DR-only groups, Figure 1). Food intake in the cross-
over males under AL was higher than the average AL only
group, resulting in higher body mass after 1 year of the
experiments (Figure 1B) and on average a higher degree of
restriction (around 45%). However, rates of body mass
changes before the first crossover were not significantly dif-


































































































































rol mice. (A,B) Body mass curves for female (A) and male (B) mice.
ere was no difference in body mass or food intake between the
ed group on day 0. Data represent means ± SEM from N= 6 to 10
d) mice in the control groups. (C,D) Rates of body mass change with
re calculated by linear regression for time points within an
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ak).
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AL control mice peaked slightly before that of female AL
controls. Weight loss at high age was also seen in DR con-
trol mice, however, it was of lower magnitude and its onset
was delayed by about 150 to 200 days (Figure 1A,B).
During the crossovers to AL, food intake initially
increased (hyperphagia) in both sexes. However, it stabilized
in females at baseline level, while it remained higher than
baseline in males (P <0.001 [see Additional file 1: Figure
S1]). Following the first crossover into AL, body mass
increased over the 5 months (repeated measures: P <0.001)
in both sexes. However, despite increased food intake in
males after the DR-AL crossover, body mass increased
more slowly after DR than in AL-only animals (Figure 1D).
This was not the case for females, where body mass gain
after switch to AL was at the same rate as in AL-only con-
trols (Figure 1C). This difference between sexes was con-
firmed after the second crossover to AL feeding: Following
5 months of adult-onset DR, body mass of females
increased even faster than in AL-only controls, while rates
of increase remained low for males (Figure 1C,D) despite
increased food intake [see Additional file 1: Figure S1].
Accordingly, females returned to baseline body mass after
5 months while in males, body mass was maintained below
baseline until the end of the experiment (P <0.001).
Following the crossovers from AL to DR, males
showed stronger responses in body weight than females,
approaching the body weight of DR-only animals more
closely (following the first crossover) or even losing
weight below that level (after the second crossover). This
might be due to the above-normal food intake in the
male crossover mice during AL periods resulting in
more severe dietary restriction.
There were no depot-specific changes in fat mass fol-
lowing the first or second crossover in either sex. All
changes in fat masses at any point in the experiment were
fully proportional to the respective body mass changes. In
long-term controls dissected aged 12, 15 or 24 months,
the decreased mass of all the organs in DR mice was en-
tirely on account of the reduced body mass. In males there
were no significant differences in relative organ mass per
total body mass induced by the crossovers. In females, the
relative masses of the kidneys were significantly less in DR
mice after the first (P=0.003) and second (P=0.011)
crossover, and the liver (P=0.044) only after the second
crossover.
In summary, males, but not females, maintained low
body mass with slow mass gains after return to AL feed-
ing from either early-onset or late-onset DR, despite
increased food intake.
Glucose tolerance
We next assessed glucose tolerance immediately before
and at different time points after first and secondcrossover. DR mice were more glucose tolerant than AL
mice at baseline in both sexes (Figure 2). In female mice,
glucose tolerance responded only minimally to changes
in the feeding regimen. Females in the DR-AL-DR group
maintained the same glucose tolerance levels throughout
the experiment (P= 0.245). However, females that were
crossed over to DR at 15 months of age improved their
glucose tolerance resulting in a significant difference
(P= 0.022) by 12 weeks after the first crossover. No dif-
ferences were detectable between the groups following
the second crossover.
Glucose tolerance in male mice was more responsive to
changes in the feeding regime and showed highly signifi-
cant changes over time within both groups (P <0.001).
Following either the first or second crossover to DR, glu-
cose tolerance improved fully within 6 weeks (P <0.001,
Figure 2B). However, following the inverse crossover to
AL, glucose tolerance in males reached AL baseline levels
only at 12 weeks after the first crossover and remained sig-
nificantly improved over baseline up to the end of the ex-
periment after the second crossover (P=0.001, Figure 2B).
Together, these data show that adult-onset DR induced
a lasting improvement in glucose tolerance in males,
which paralleled the maintenance of low body mass.
Conversely, a short-term reversion from DR did not re-
sult in longer lasting impairment in glucose tolerance.
Glucose tolerance in females was much less influenced
by feeding regime.
Fasting glucose, insulin and insulin sensitivity
In agreement with the sex differences seen in body mass
maintenance and glucose tolerance, males and females
also showed different responses in fed and fasting glu-
cose concentrations and insulin levels to dietary change.
Male DR mice had lower fed (Figure 3B) and fasting glu-
cose (Figure 3D) and insulin (Figure 3F) levels at base-
line (all P <0.001) and all parameters were highly
affected by the crossovers (P <0.001). With the excep-
tion of fasting insulin after the first crossover, all para-
meters were completely reverted from baseline AL levels
within 6 weeks after the crossover to DR. When male
mice were crossed back to AL from either long-term or
short-term DR, changes in glucose were also completed
within 6 weeks after the crossover. However, fasting in-
sulin levels in male mice crossed over to AL after a
period of DR remained below the AL baseline for at least
12 weeks, both after long-term and short-term DR. Insu-
lin sensitivity as evaluated by the homeostasis model as-
sessment 2 (HOMA2) protocol was reversed by
12 weeks (P <0.001) after the first cross and by 6 weeks
(P= 0.008) after the second crossover in males. By the
end of the experiment, males exposed to a (DR-AL-DR)
regime had significant improvements in insulin sensitiv-






































































































Figure 2 Glucose tolerance in female (F; (A)) and male (M; (B)) mice during double crossover. Data were calculated as the area under the
curve (AUC) following a glucose injection and represent means ± SEM from N= 6 to 10 mice/group. Asterisks denote significant differences
between groups (*P <0.05; **P <0.001), assessed using one-way analysis of variance (ANOVA). In male AL-DR-AL mice, glucose tolerance was
significantly better at the end than at baseline (P <0.001). AL = ad libitum; DR = dietary restriction.
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tive correlation between fasting insulin and glucose (AL-
DR-AL: R2 = 0.075, P= 0.050; DR-AL-DR: R2 = 0.177,
P= 0.001) and between AUC of glucose clearance and
insulin concentrations (AL-DR-AL: R2 = 0.174, P= 0.001;
DR-AL-DR: R2 = 0.179, P= 0.003).
In female mice, fed glucose levels were reduced follow-
ing the first crossover to a DR regime and this was
reverted by crossing back to AL (Figure 3A). Fasting glu-
cose (Figure 3C) and insulin (Figure 3E, borderline sig-
nificance) were lower at baseline as expected. However,
changes over time and differences between the groups infasting glucose and insulin concentrations were generally
too small in females to show consistent patterns with
the available numbers of animals.
In male mice, glucose tolerance and insulin sensitivity
were strongly affected by the crossover regimes. To estab-
lish the impact of body mass on these effects, correlations
between body mass and the measured parameters were cal-
culated. Body mass was positively related to fasting glucose
and insulin (glucose; AL-DR-AL: R2=0.355, P <0.001; DR-
AL-DR: R2=0.380, P <0.001 and insulin; AL-DR-AL:
R2=0.186, P=0.002; DR-AL-DR: R2=0.270, P <0.001).


















































































































































































































































































Figure 3 Glucose and insulin levels in female (F; (A,C,E)) and male (M; (B,D,F)) mice during double crossover. Fed glucose (A,B) was
measured at 11.30 am when mice were postprandial. Fasting glucose (C,D) and fasting insulin (E,F) were measured following an overnight fast.
Data represent means ± SEM from N= 6 to 10 mice/group. Asterisks denote significant differences between groups (*P <0.05; **P <0.001),
assessed using one-way analysis of variance (ANOVA).
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R2=0.343, P <0.001; DR-AL-DR: R2=0.351, P <0.001).
There was a significant positive correlation between AUC
of glucose clearance and body mass in males (AL-DR-AL:
R2=0.603, P <0.001; DR-AL-DR: R2=0.213, P <0.001).
This was also significantly correlated in females, but only in
the AL-DR-AL group (R2=0.356, P <0.001) [see Additional
file 3: Figure S3].
Together, these data show that even a short period of
DR induces improvements of fasting insulin levels, glu-
cose tolerance and body mass maintenance that can last
considerably in males while they are of smaller magni-
tude and more quickly reversed in females.DR effects on longevity and tumor prevalence
Lowering of circulating insulin levels and improvement of
glucose tolerance are seen as important mediators of the
lifespan-improving and health-improving effects of DR
[4,5]. Given the sexual dimorphism in the response of these
parameters to DR shown above, different degrees of health-
related and lifespan-related effects of DR between males
and females might be expected. The present study was not
designed to analyze long-term health and lifespan effects
after short-term DR, and frequencies of death occurring inthe four crossover groups until the end of the experiment
were not significantly different (data not shown). However,
data on lifespan (Figure 4) and tumor prevalence at death
(Table 1) are available from the large AL and DR only con-
trol cohorts. Lifespans of male and female mice under AL
feeding were not different from each other (P=0.192).
Median lifespans were 27±0.61 months for AL males and
28±0.41 months for AL females. DR improved survival in
both sexes, but the extension was significantly greater in
females (P=0.0163). Median lifespan increased by about
26% to 34±0.78 months in males, and by at least 32% to
>37 months in females. Under AL feeding, tumor preva-
lence increased sharply in both sexes after 17 months of
age, but percentages of tumor-bearing mice remained lower
in males than in females over their whole remaining life-
span (Table 1). DR strongly reduced tumor prevalence in
females. In males, however, DR appeared to postpone
tumor incidence but did not reduce the percentages of
mice bearing neoplasms after 20 months of age (Table 1).Discussion and Conclusion
This study addresses two related questions: firstly, is
there a ‘metabolic memory’ if mice are switched between
AL and DR feeding regimens?
Age (months)
















Figure 4 Lifespan in ad libitum (AL) only and dietary restriction
(DR) only male and female control mice. Right - censored Kaplan-
Meier curves, dots represent censoring events.
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tween DR and AL feeding regimes can be a very dynamic
process, particularly in terms of survival and metabolic
status with reversal of feeding regimes resulting in a rapid
change in ageing trajectory in Drosophila [12] and in rats
[13]. Markers of oxidative damage were found to be
reversed with the feeding regime in flies [14], and in the
brains of mice [15]. In mice, gene expressions profiles in
liver, muscle and hypothalamus shifted quickly in corres-
pondence to a new feeding regime [16], including genes
involved in metabolism and growth control. In rats, effects
of short-term to medium-term early-onset DR were found
to be obliterated by a later period of AL feeding [13].Table 1 Number (%) of neoplasm-bearing mice/number
of mice examined
Age at death F AL F DR M AL M DR
12 ± 1 months 2/22 (9.1) 2/19 (10.5) 0/19 (0.0) 0/24 (0.0)
17 ± 1 months 8/41 (19.5) 0/15 (0.0) 4/45 (8.9) 0/34 (0.0)
20 ± 1 months 13/21 (61.9) 0/16 (0.0) 9/20 (45.0) 1/5 (20.0)
23 ± 1 months 24/47 (51.1) 7/35 (20.0) 12/31 (38.7) 5/11 (45.5)
26 ± 1 months 18/34 (52.9) 0/6 (0.0) 15/61 (24.6) 13/48 (27.1)
29 ± 1 months 16/30 (53.3) 3/31 (9.7) 2/24 (8.3) 4/25 (16.0)
32 ± 1 months 22/37 (59.5) 15/41 (36.6) 11/36 (30.6) 8/58 (13.8)
35 ± 1 months 1/8 (12.5) 5/36 (13.9) 7/34 (20.6)
37 months 2/20 (10.0)We found that male mice retained a ‘metabolic memory’,
that is, improved body mass maintenance, glucose tolerance
and fasting insulin levels for up to 5 months after a period
of adult-onset DR. A similar experiment has been per-
formed in the same strain of male mice whereby AL mice
were crossed to DR feeding at 11 months of age and vice
versa [17]. No second crossover was performed in this
study, but follow-up time was for 10 months after cross-
over. This study also shows that in males crossed from DR
to AL, body mass remained below long-term AL levels. Fat
mass remained below control levels for at least 6 months
after crossover to AL. Importantly, glucose tolerance did re-
main significantly improved compared to long-term AL
controls for the whole observation period (10 months after
the crossover). This reinforces the suggestion that meta-
bolic memory of DR is retained in male mice in terms of
improved glucose tolerance.
The second question was, are sex-specific responses in
insulin, glucose tolerance and body weight maintenance
associated with the longevity effect of DR?
In our study, AL females showed better glucose toler-
ance, fasting glucose and fasting insulin levels than AL
males, and these were largely unaffected following short-
term or long-term DR. In contrast, glucose and insulin
levels and glucose tolerance were more responsive to peri-
ods of DR in males confirming published data [9] and to-
gether with body mass maintenance, showed lasting
improvements following a period of DR. Fasting glucose
and insulin concentrations positively correlated with body
mass, as previously reported [18], with a subsequent nega-
tive correlation between body mass and insulin sensitivity
[7]. This suggests that the function of pancreatic β cells to
secrete insulin was not impaired in AL mice.
There is extensive evidence showing general sexual di-
morphism in insulin sensitivity. Several factors could be re-
sponsible for this. One is the influence of sex hormones;
testosterone has a direct effect upon pancreatic islet func-
tion by favoring insulin gene expression and insulin release
[19]. Estrogen has beneficial effects on glucose tolerance
and insulin resistance: for example, women are more likely
to develop diabetes after menopause but hormone replace-
ment therapy can ameliorate this tendency [20], and in
ovariectomized mice, administration of estrogen protected
against glucose intolerance induced by high fat diet in an
estrogen receptor alpha dependent manner [21]. Further-
more, sexual dimorphism in adipokines that regulate insu-
lin sensitivity such as resistin, leptin, adiponectin, retinol
binding protein 4 (RBP4) and glucocorticoids has been
shown [22-26]. Additional factors, such as the capacity of
peripheral organs, primarily skeletal muscle, to uptake glu-
cose might also influence gender differences in insulin sen-
sitivity and glucose tolerance.
There is also ample evidence for a sexual dimorphism in
response to lifespan-extending manipulations. In mice, the
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receptor I [27], or feeding with the mammalian target of
rapamycin (mTOR) inhibitor rapamycin [28] were found to
be more robust in females than males. Similarly, reduction
of the activity of the insulin-signaling pathway [29], or the
mTOR pathway by deletion of S6K [30] extended lifespan
only in female but not in male mice. Also in Drosophila,
females tend to show enhanced responses to various lifespan
extension manipulations as compared to their male counter-
parts. For example, dFOXO overexpression in fat body
extended lifespan in females but not in males in Drosophila
[31]. Female flies show greater extension of lifespan by DR
than males [32]; the reason is not completely clear while the
reduction in egg laying activity in female DR flies has been
postulated to be one possible explanation. There is contra-
dictory evidence regarding a sexual dimorphism in the life-
span response to DR in C57BL/6 mice. Blackwell [33]
reported identical lifespan between the sexes in both AL
control and DR mice. Using single-housed animals, Turturro
et al. [34,35] showed larger lifespan extension under DR in
females, however, this was driven by a shorter lifespan in AL
females as compared to AL males. Group-housed animals in
our cohort reached higher median ages already under AL,
which were not different between sexes. However, lifespan
was more extended by DR in females than in males.
It had been suggested that the effects of DR on lifespan
are mitigated through circulating insulin levels, which may
reduce insulin signaling [4,5]. However, longer lifespan and
better glucose tolerance are not always associated with each
other. For example, insulin receptor substrate 1 null mice
had extended lifespan together with lifelong mild glucose
intolerance [27], and Harper et al. [36] reported that a
long-lived mouse stock had impaired glucose tolerance
compared to control mice. According to our data on AL
females and males, the lower fasting insulin levels in AL
females are not associated with longer lifespans, and
tumors are, if anything, more frequent in AL females rela-
tive to AL males. In case of DR mice, lifelong DR results in
greater extension of lifespan and more prominent tumor
suppression in females than in males despite both sexes dis-
playing indistinguishable glucose tolerance and insulin sen-
sitivity. The interconnections between sexual dimorphisms
in metabolic and lifespan regulation appear to be more
complex than originally thought. Whether the retention of
a ‘metabolic memory’ in male mice after a brief period of
DR in mid life improves their health/lifespan beyond the
period in which they maintain better glucose tolerance and
lower body mass remains to be elucidated.
Methods
Mice
All mice were inbred C57BL/6 (Harlan, Blackthorn UK)
and both males and females were used. Ethical approval
was granted by the LERC Newcastle University, UK. Thework was licensed by the UK Home Office (PPL 60/3864)
and complied with the guiding principles for the care and
use of laboratory animals.
Mice were housed in same-sex cages in groups of 4 to 6
(56 × 38× 18 cm, North Kent Plastics, Kent, UK) and indi-
vidually identified by an ear notch. They were provided
with sawdust, paper bedding and environmental enrich-
ment (a plastic house). Mice were housed at 20± 2°C
under a 12 h light/12 h dark photoperiod with lights on at
7.00 am. The diet used was standard rodent pelleted chow
(CRM (P); Special Diets Services, Witham, UK) for AL-fed
mice and the same diet, but as smaller pellets were offered
to DR mice. The smaller pellet size reduced competition
for food. DR mice were offered 60% of AL intake (calcu-
lated based on average food intake in 90 control AL mice
between 5 and 12 months of age) as one ration at 9.30 am
daily. All mice were fed AL until 3 months of age and then
split into AL or DR groups, matched for body mass and
food intake (N=10/sex/group for crossover groups). At
15 months of age, mice were crossed over from DR to AL
or AL to DR. After a further 140 days (about 20 months of
age), these mice were returned to the original feeding re-
gime for a further 160 days, until they were killed at an
age of 25 months, resulting in four experimental groups:
male AL-DR-AL, male DR-AL-DR, female AL-DR-AL and
female DR-AL-DR. During the experiment three females
and four males died or were killed from the AL-DR-AL
group, and one female and four males from the DR-AL-
DR group. Effects of DR on body mass, survival and tumor
prevalence were monitored in long-term controls which
were fed only DR or AL from 3 months of age, comprising
280 mice/sex/group in total. These were either killed at
predetermined ages or left to die naturally. All mice were
dissected and macroscopically examined for tumor preva-
lence at death.
Body mass, body composition and food intake
Body mass and food intake were measured at least once a
month in AL mice and once a week in DR mice (± 0.01 g;
Sartorius top-pan balance, Epsom, UK). Mean food intake
of each AL cage was measured by weighing the contents
of the food hopper on 2 consecutive days and this amount
divided by the number of mice in the cage. Food intake in
the double-crossover mice over the course of the experi-
ment is shown in Additional file 1. Average food intake in
the crossover males under AL was higher than in the AL
only controls. However, during the last weeks before
crossover, the degree of DR was not significantly different
from 40% in either males or females. Full body dissection
was performed at all endpoints and the organs weighed
(Ohaus analytical balance, ± 0.0001 g; Ohaus Corp., NJ,
USA): brain, heart, lungs, thymus, quadriceps, tail, cae-
cum, liver, kidneys, spleen, gonads and pancreas. Also,
large intestine and small intestine mass (after flushing with
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ition, six fat depots were also fully dissected and weighed:
retroperitoneal, gonadal, mesenteric, subcutaneous, sub-
scapular and brown adipose tissue (BAT).Glucose tolerance test
A glucose tolerance test (GTT) was performed on each
individual in the crossover experiment at 15 months old
(baseline) and then at 1, 3 and 12 weeks after the first
crossover and 1, 3 and 12 weeks after the second cross-
over. The GTT was performed on fasting mice by re-
moving all food from AL mice at 6.00 pm the evening
before (15.5 h fasting) and withholding the daily food ra-
tion from DR mice until after the test. Drinking water
was available throughout. A 20% glucose solution was
prepared fresh each morning using D-glucose (G-5767,
Sigma-Aldrich, St Louis, MO, USA) and sterile filtered
water. A fasting blood sample was collected by placing
each mouse in a restrainer and nicking the tail vein with
a scalpel blade. A total of 200 μl of blood was collected
from each animal in a microvette container lined with
lithium-heparin (Microvette, Sarstedt AB, Landskrona,
Sweden). Blood was centrifuged and the resultant plasma
stored at −80 °C. The fasting blood glucose level (mol/l)
(time-point 0) was determined using a Glucometer (ACCU-
CHEK Aviva Nano, Mannheim, Germany) from a further
approximately 2 μl of blood. Then, mice were injected intra-
peritoneally with 2 g/kg body mass of the glucose solution.
At 15, 30, 60 and 120 minutes post injection the blood glu-
cose level was measured using blood from the tail vein on
the Glucometer as above. At the end of the GTT, DR mice
were fed their daily ration and food was replenished in AL
food hoppers. Glucose tolerance was expressed as the area
under the curve over the 120-minute test duration. On a
separate occasion, at least 3 days before or after a GTT, fed
glucose blood concentrations were measured using a drop of
blood from the tail on the Glucometer as above, at 11.30 am
to ensure mice were postprandial.Fasting plasma insulin levels and insulin sensitivity
Using the fasting plasma collected prior to the GTT, in-
sulin concentrations were measured using an ultrasensi-
tive mouse insulin ELISA kit (CrystalChem Inc.,
Downers Grove, IL, USA). All samples were run in du-
plicate and a number of additional standards were
included because the concentrations measured were
close to the detection limit. Insulin sensitivity was esti-
mated using the updated homeostatic model assessment
(HOMA2) model which gives an estimate of insulin sen-
sitivity using fasting plasma insulin and glucose concen-
trations [37]. This model can be used as a comparison
between experimental groups as a measure of insulin
sensitivity in rodents [38].Statistical analysis
All statistical analyses were performed using Minitab
V. 16 (Minitab Inc., State College, PA, USA) and Sig-
maplot V. 11.0 (SPSS, Chicago, IL, USA). Repeated
measures analysis of variance (ANOVA) was used
when analyzing changes in body mass and food intake
data over time. Fat and organ mass co-vary with body
mass, therefore mass was used as a covariate in a gen-
eral linear model (GLM) to control for these effects.
One-way ANOVA was used to find differences be-
tween groups. A Tukey comparison was included in
the one-way ANOVA to determine differences between
all the measured timepoints within the same group.
Linear least squares regression was used to find signifi-
cant correlations between two continuous factors.
Kaplan-Meier survival curves were compared by log-
rank test. Differences were considered significant when
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